Skip to main content

Table 2 Treatment outcome

From: Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania

Outcome PCR uncorrected PCR corrected
Under-fives (n = 51)*   
Early Treatment Failure (ETF) 0 (0%) 0 (0%)
Late Clinical Failure (LCF) 3 (5.6%)*** 0 (0%)
Late Parasitological Failure (LPF) 8 (15.7%)*** 0 (0%)
Adequate Clinical and Parasitological Response (ACPR) 40 (78.4%) 40 (100%)
Children aged ≥5 years (n = 28)**   
Early Treatment Failure (ETF) 0 (0%) 0 (0%)
Late Clinical Failure (LCF) 1 (3.6%)*** 0 (0%)
Late Parasitological Failure (LPF) 6 (21.6%)*** 0 (0%)
Adequate Clinical and Parasitological Response (ACPR) 21 (75.0%) 21 (100%)
Overall Adequate Clinical and Parasitological Response (ACPR) 61 (77.2/%) 61 (100/%)
  1. *5 lost to follow-up, **4 lost to follow-up.
  2. ***PCR Genotyping showed that they were new infections.